Safety and Efficacy of SUM-191 for Patients With Bacterial Conjunctivitis

NCT07565103 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

426

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Conjunctivitis

Interventions

DRUG: SUM-191
DRUG: Placebo

Sponsor

Senju USA, Inc.